In 2004-6 60% of product launches were in specialist driven markets with oncology alone contributing to 11% of global growth (source IMS consulting). This shift in portfolios presents challenges to pharmaceutical companies, many of whom have resources focused on the primary care sector. These changes are leading to changes not only in the size of teams but also the way in which they are resourced.

Pharmaceutical companies are now repeatedly asking us for secondary care specialists and, having built more than 22 secondary or specialist teams in the UK alone we have built a raft of expertise that is now at the disposal of our customers.

More than 40% of all UK hospital representative positions are now filled by Innovex and our sister company Royce. With direct access to the very best people and a broad range of integrated services Innovex can deliver against your objectives in both secondary and specialist care.

Voted the number 1 CSO by the readers of Pf magazine in 2007 – for the 6th year running – and retention on our secondary care projects now at a staggering 98% we are best placed to attract and retain the right candidates whatever the size or focus of your project.

Our experience in single or multiple countries means we can bring a wealth of expertise and flexibility to drive success for you.

If you would like more information about how Innovex could help you contact science@innovex.com or call +441344 601500 and ask for business development.

If you would like a career at Innovex in secondary or specialist sales visit www.innnovexcareers.com.